semaglutide if not overweight GLP-1 Overweight: Biomarker & Clinical Criteria – PlexusDx Can I use Weight Loss

Total spending on GLP-1 medications in the US skyrocketed by over 500% from 2018 to 2023, rising from $13.7 billion to $71.7 billion

These medications clearly work best when patients are also coached on behavior change

Cui K, Zhang L, La X, Wu H, Yang R, Li H, Li Z (2022) Ferulic acid and p-coumaric acid synergistically attenuate non-alcoholic fatty liver disease through HDAC1/PPARG-mediated free fatty acid uptake

Conservative protocols use 200-300 mcg total once daily before bed for anti-aging and general body makeup research

For researchers, the path forward involves continued, independent study of each compound